For more than a decade, one of America's largest retailers allowed its pharmacy network to become a conduit for opioid misuse — not through ignorance, but through a quiet institutional choice to place revenue above responsibility. The Department of Justice and DEA have now settled with Walmart for $50 million, closing a case that began under one administration and was carried forward by another, a rare continuity that underscores how seriously federal authorities regarded the harm done. At its heart, this story is not merely about a corporation paying a fine; it is about the moment when a comp
Walmart settles $50M opioid prescription case with DOJ
Thousands of invalid opioid prescriptions were filled, contributing to the nation's opioid epidemic and exposing patients to dangerous controlled substances.